3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Oropharyngeal Neoplasms
11
Lung Neoplasms
8
Carcinoma
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Hypopharyngeal Neoplasms
6
Nasopharyngeal Carcinoma
5
Mesothelioma, Malignant
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Interventions
Nivolumab
2
Ipilimumab
2
spartalizumab
1
poly ICLC
1
balstilimab
1
atezolizumab
1
Specimen Handling
1
Sorafenib
1
Irinotecan
1
DT2216
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
90 days
×
Clear all
No trials found.